Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). (Q42247741)

19 October 2017

Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS). (English)

1 reference

antiphospholipid syndrome

19 October 2017

1 reference

5

1 reference

19 October 2017

17

Y Shoenfeld

1 reference

19 October 2017

8

M Blank

1 reference

19 October 2017

Gisele Zandman-Goddard

4

object named as

G Zandman-Goddard

1 reference

19 October 2017

Ricard Cervera i Segura

6

object named as

R Cervera

1 reference

19 October 2017

15

A Tincani

1 reference

19 October 2017

1

N Agmon-Levin

1 reference

19 October 2017

16

A Doria

1 reference

19 October 2017

3

B-S Porat Katz

1 reference

19 October 2017

C Rosário

2

1 reference

19 October 2017

L Stojanovich

7

1 reference

19 October 2017

Ss Pierangeli

9

1 reference

19 October 2017

S Praprotnik

10

1 reference

19 October 2017

E de Meis

11

1 reference

19 October 2017

L Parente Seguro

12

1 reference

19 October 2017

A Ruffatti

13

1 reference

19 October 2017

V Pengo

14

1 reference

19 October 2017

language of work or name

1 reference

13 September 2013

1 reference

19 October 2017

1 reference

19 October 2017

22

1 reference

19 October 2017

13

1 reference

19 October 2017

1327-1335

1 reference

Ferritin for the clinician

19 October 2017

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

The ferritins: molecular properties, iron storage function and cellular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Regulation of ferritin genes and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Embryonic genes expressed in Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Effects of isoferritins on human granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Ten years of clinical experience with adult onset Still's disease: is the outcome improving?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Synovial fluid ferritin in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Serum ferritin as a serologic marker of activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Ferritin in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Antiphospholipid syndrome infectious origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Current knowledge regarding Asherson's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Livedo reticularis as a criterion for antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Are oxidized LDL/beta2-glycoprotein I complexes pathogenic antigens in autoimmune-mediated atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Cardiac manifestations in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Increased ferritin gene expression in atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Cerebral manifestations in the antiphospholipid (Hughes) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Increased expression of ferritin, an iron-storage protein, in specific regions of the parahippocampal cortex of epileptic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Neurologic manifestations of the antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Infections and autoimmunity--friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Infections and vaccines in the etiology of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Human parvovirus B19 infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Viral infections and antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

How viral infections affect the autoimmune process leading to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313504633

21 January 2018

Identifiers

DOI

10.1177/0961203313504633

1 reference

19 October 2017

1 reference